A report on 1211 men with PCa who were undergoing active surveillance, including 11, 11, and 5 with BRCA1, BRCA2, and ATM germline carriers, respectively, revealed that BRCA2 carriers are more likely to undergo a tumor grade re-classification in subsequent biopsies [50]. The gene discussed is BRCA2; the disease is posterior cortical atrophy.